Key terms

About IMNN

Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest IMNN news

Apr 11 8:13am ET Imunon reports compliance with Nasdaq listing requirements by TipRanks Apr 01 6:20am ET Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Legend Biotech (LEGN) and Imunon (IMNN) by TipRanks Apr 01 6:15am ET Imunon price target raised to $13 from $12 at H.C. Wainwright by TipRanks Mar 28 8:06am ET Imunon sees cash runway into 4Q24 by TipRanks Mar 28 8:05am ET Imunon reports 2023 EPS ($2.16) vs. ($5.03) last year by TipRanks Mar 25 8:53am ET Imunon receives $1.3M from sale of New Jersey NOLs by TipRanks Mar 13 12:30pm ET Analysts Offer Insights on Healthcare Companies: Imunon (IMNN) and CalciMedica (CALC) by TipRanks Mar 13 12:15pm ET Imunon timelines unchanged despite CEO departure, says H.C. Wainwright by TipRanks Mar 13 8:19am ET Imunon files IND application to begin human testing of IMNN-101 by TipRanks Mar 12 5:23pm ET Imunon Announces CEO Resignation and Interim Leadership Transition by TipRanks Mar 12 5:01pm ET Imunon CEO Le Goff resigns by TipRanks Feb 29 8:40am ET Imunon announces lab confirms immunogenicity, protection with IMNN-101 by TipRanks Feb 27 8:40am ET Imunon announces Memorial Sloan Kettering Cancer center enrolling patients by TipRanks Feb 22 8:21am ET Imunon announces article on IMNN-101 preclinical data by TipRanks

No recent press releases are available for IMNN

IMNN Financials

1-year income & revenue

Key terms

IMNN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

IMNN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments